% | $
Quotes you view appear here for quick access.

MultiCell Technologies, Inc. Message Board

  • gravity_master1 gravity_master1 Sep 17, 2013 10:16 AM Flag

    3 Big Biotech Buyouts of 2013

    The Chinese calendar says 2013 is the year of the snake, but the market says it's the year of biotech. Major biotechnology ETFs and indices have walloped the broader market by more than 25% since the beginning of the year.
    Acquisition No. 1: Onyx Pharmaceuticals In August, Amgen (NASDAQ: AMGN acquired Onyx Pharmaceuticals for $9.7 billion
    Acquisition No. 2: Elan In July, Perrigo (NYSE: PRGO ) bought Elan for $8.6 billion.
    Acquisition No. 3: Omthera In May, AstraZeneca (NYSE: AZN ) bought Omthera for $443 million.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.00020.0000(0.00%)May 27 3:41 PMEDT